Doctors in Mexico have developed a type of biomaterial known as Titanium Oxygen Alloy, designed for implantation in the brain for long-term and precise drug delivery.
Epilepsy is a common neurological disorder worldwide. In Mexico, the prevalence of this condition is approximately 3%, with up to 80% of patients unable to achieve complete remission.
The Neurosurgical Research Institute and the Autonomous University in Mexico City have collaborated to develop this Titanium Oxygen Alloy biomaterial. This alloy is formed into a cylindrical tube that contains medication, which is then implanted into brain tissue for sustained and targeted drug delivery.
This alloy, once implanted in the brain, does not elicit rejection or inflammation. Currently, Mexican scientists are experimenting with this biomaterial on mice to treat epilepsy.
In the future, tests will expand to cats and monkeys, and ultimately, they plan to conduct trials on humans.
Treating epilepsy using this method is cost-effective, straightforward, and has the potential for broader applications in treating other neurological disorders such as heart rhythm issues and excessive sleepiness. This represents a promising approach with high application potential.
Tuyet Nhung
